Broomfield, CO based Accera, Inc., a drug development company focused on Alzheimer’s disease and related neurodegenerative diseases, announced it has recently closed a Series B financing of $7.5M led by returning investors Inventages Venture Capital, POSCO BioVentures and several unnamed private investors. In 2004 Accera closed their $6M Series A round.
Based upon their Neuron [...]